Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2019 Feb;11(2):351-353.
doi: 10.21037/jtd.2018.11.111.

Immune checkpoint inhibitors in esophagogastric cancer: still a long way to go

Christos Fountzilas  1 , Steven N Hochwald  2
Affiliations
Editorial

Immune checkpoint inhibitors in esophagogastric cancer: still a long way to go

Christos Fountzilas et al. J Thorac Dis. 2019 Feb.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: The authors have no conflicts of interest to declare.

Comment on

References

    1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011;144:646-74. 10.1016/j.cell.2011.02.013 - DOI - PubMed
    1. Zhang H, Xu X. Mutation-promoting molecular networks of uncontrolled inflammation. Tumour Biol 2017;39:1010428317701310. 10.1177/1010428317701310 - DOI - PubMed
    1. Le DT, Uram JN, Wang H, et al. PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. N Engl J Med 2015;372:2509-20. 10.1056/NEJMoa1500596 - DOI - PMC - PubMed
    1. Muro K, Chung HC, Shankaran V, et al. Pembrolizumab for patients with PD-L1-positive advanced gastric cancer (KEYNOTE-012): a multicentre, open-label, phase 1b trial. Lancet Oncol 2016;17:717-26. 10.1016/S1470-2045(16)00175-3 - DOI - PubMed
    1. Doi T, Piha-Paul SA, Jalal SI, et al. Safety and Antitumor Activity of the Anti-Programmed Death-1 Antibody Pembrolizumab in Patients With Advanced Esophageal Carcinoma. J Clin Oncol 2018;36:61-7. 10.1200/JCO.2017.74.9846 - DOI - PubMed